The global cardiac valvulotome market size is evaluated at USD 121.34 million in 2025 and is forecasted to hit around USD 184.51 million by 2034, growing at a CAGR of 4.77% from 2025 to 2034. The North America market size was accounted at USD 46.35 million in 2024 and is expanding at a CAGR of 4.89% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cardiac Valvulotome Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cardiac Valvulotome Market Revenue and Volume, by Device Type
8.1.1 Balloon Valvulotomes
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Cutting/Excising Valvulotomes
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Surgical Valvulotomes
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Hybrid Scoring-Ablation Valvulotomes
8.1.4.1. Market Revenue and Volume Forecast
9.1. Cardiac Valvulotome Market Revenue and Volume, by Indication
9.1.1. Pulmonary Valve Stenosis
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Tricuspid Valve Stenosis/Regurgitation
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Mitral Commissurotomy
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Aortic Valve Scoring
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Other (Eustachian Valve, Accessory Leaflet Release)
9.1.5.1. Market Revenue and Volume Forecast
10.1. Cardiac Valvulotome Market Revenue and Volume, by End User
10.1.1. Tertiary Care & Cardiac Centers
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. General Hospitals & Cath Labs
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Ambulatory Surgical Centers
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Specialty Clinics (Pediatrics, Rheumatology)
10.1.4.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Device Type
11.1.2. Market Revenue and Volume Forecast, by Indication
11.1.3. Market Revenue and Volume Forecast, by End User
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Device Type
11.1.4.2. Market Revenue and Volume Forecast, by Indication
11.1.4.3. Market Revenue and Volume Forecast, by End User
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Device Type
11.1.5.2. Market Revenue and Volume Forecast, by Indication
11.1.5.3. Market Revenue and Volume Forecast, by End User
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Device Type
11.2.2. Market Revenue and Volume Forecast, by Indication
11.2.3. Market Revenue and Volume Forecast, by End User
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Device Type
11.2.4.2. Market Revenue and Volume Forecast, by Indication
11.2.4.3. Market Revenue and Volume Forecast, by End User
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Device Type
11.2.5.2. Market Revenue and Volume Forecast, by Indication
11.2.5.3. Market Revenue and Volume Forecast, by End User
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Device Type
11.2.6.2. Market Revenue and Volume Forecast, by Indication
11.2.6.3. Market Revenue and Volume Forecast, by End User
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Device Type
11.2.7.2. Market Revenue and Volume Forecast, by Indication
11.2.7.3. Market Revenue and Volume Forecast, by End User
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Device Type
11.3.2. Market Revenue and Volume Forecast, by Indication
11.3.3. Market Revenue and Volume Forecast, by End User
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Device Type
11.3.4.2. Market Revenue and Volume Forecast, by Indication
11.3.4.3. Market Revenue and Volume Forecast, by End User
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Device Type
11.3.5.2. Market Revenue and Volume Forecast, by Indication
11.3.5.3. Market Revenue and Volume Forecast, by End User
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Device Type
11.3.6.2. Market Revenue and Volume Forecast, by Indication
11.3.6.3. Market Revenue and Volume Forecast, by End User
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Device Type
11.3.7.2. Market Revenue and Volume Forecast, by Indication
11.3.7.3. Market Revenue and Volume Forecast, by End User
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Device Type
11.4.2. Market Revenue and Volume Forecast, by Indication
11.4.3. Market Revenue and Volume Forecast, by End User
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Device Type
11.4.4.2. Market Revenue and Volume Forecast, by Indication
11.4.4.3. Market Revenue and Volume Forecast, by End User
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Device Type
11.4.5.2. Market Revenue and Volume Forecast, by Indication
11.4.5.3. Market Revenue and Volume Forecast, by End User
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Device Type
11.4.6.2. Market Revenue and Volume Forecast, by Indication
11.4.6.3. Market Revenue and Volume Forecast, by End User
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Device Type
11.4.7.2. Market Revenue and Volume Forecast, by Indication
11.4.7.3. Market Revenue and Volume Forecast, by End User
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Device Type
11.5.2. Market Revenue and Volume Forecast, by Indication
11.5.3. Market Revenue and Volume Forecast, by End User
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Device Type
11.5.4.2. Market Revenue and Volume Forecast, by Indication
11.5.4.3. Market Revenue and Volume Forecast, by End User
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Device Type
11.5.5.2. Market Revenue and Volume Forecast, by Indication
11.5.5.3. Market Revenue and Volume Forecast, by End User
12.1. Medtronic
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Edwards Lifesciences
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Boston Scientific
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cook Medical
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Terumo
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Philips (Spectranetics)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. LivaNova
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Micro Interventional Devices
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. B. Braun
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description